Bengaluru, Sept. 23 -- Shares of a company manufacturing niche APIs, intermediates, and formulations and also undertakes contract research and manufacturing service, hit a 5 percent upper circuit, after EMA granted initial authorisation for medicinal products in Europe, unlocking a $2.5 billion market opportunity.

With a market cap of Rs. 8,025 crores, the shares of Shilpa Medicare Limited hit a 5 percent upper circuit at Rs. 858.1 on BSE, as against its previous closing price of Rs. 817.25. The stock has delivered negative returns of around 4 percent in one year, and has fallen by about 3 percent in the last one month.

What's the News As per the latest exchange filings, Shilpa Medicare Limited has received the Initial Authorisation fro...